1) weight variation tolerances
重量变异耐受性
2) low dose tolerance
低量耐受性
3) weight variation
重量变异
1.
We tested and analyze the weight variation of the split tablet on the basis of the dosage consistency mentioned in the USP which is applied to the whole tablet by comparing the mean FW with the mean TW of each dispensed prescription.
采用《美国药典》第24版(USP24)剂量单位一致性测定方法,将每种处方药的FW均值与其理论重量(TW)均值进行比较,分析分劈药片的重量变异性。
2.
We tested and analysed the weight variation of the split tablet on the basis of the dosage consistency metioned in the USP which is applied to the whole tablet.
方法 :收集我院由药师分劈、住院患者常用的13种处方药片 ,每种10片 ,共260个分劈片 ,采用《美国药典》剂量单位一致性测试方法分析分劈药片的重量变异性。
4) drought tolerance
耐旱性变异
1.
Studies on the drought tolerance of wild germplasm resources of Axonopus compressus in China;
中国地毯草野生种质资源耐旱性变异的初步研究
5) specific tolerance
特异性免疫耐受
1.
AIM: To develop rAAV2 containing cDNA of GAD-Ig fusion gene [GAD-Ig fusion gene is constructed by inserting glutamic acid decarboxylase(GAD) into N-terminal of murine IgG3 heavy chain(Ig)], and to study whether rAAV2 mediated GAD-Ig fusion gene expression could induce specific tolerance in IDDM animal model-nonobese diabetic (NOD) mice.
目的: 构建重组真核表达载体pSNAV- GAD -Ig[GAD- Ig融合基因是由小鼠GAD(glutamicaciddecarboxylase)基因插入到小鼠IgG3重链(Ig)基因的N端而成的 ], 制备含GAD- Ig融合基因cDNA的重组缺陷型腺相关病毒 -2 (rAAV2- GAD -Ig), 并探讨rAAV2所介导的GAD- Ig是否能诱导I型糖尿病(IDDM)动物模型 NOD(nonobesediabetic)小鼠产生特异性免疫耐受。
6) high dose tolerance
高剂量耐受性
补充资料：重量
见重力。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条